Medical Device News Magazine

Signia Integrated Xperience Hearing Aid Platform Named a Winner of the 2024 BIG Innovation Awards

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Signia Integrated Xperience (IX)

Hearing aid innovator Signia has been named a winner of the 2024 BIG Innovation Awards for its Signia Integrated Xperience (IX) hearing aid platform, which provides unprecedented sound clarity and definition for wearers in noisy group conversations – even when the wearer or speakers are in motion. The recognition underscores the company’s commitment to delivering groundbreaking solutions to all hearing aid wearers that optimize hearing capabilities in even the most challenging listening scenarios.

BIG Innovation Awards

The BIG Innovation Awards recognize organizations and products that deliver premium innovation across verticals, bringing new ideas to life that will improve the lives of users and businesses. The new Signia Integrated Xperience hearing aid platform was recognized in the Healthcare category. Past BIG Innovation Award winners include Citi Ventures, Walgreens Boots Alliance, Velcro®, Bloomfire, and Colgate-Palmolive.

“The Signia Integrated Xperience platform is truly revolutionary in its ability to deliver maximum value and unparalleled hearing capabilities to all wearers, and it’s an honor to see that innovation recognized by such a prestigious award program,” said Mike O’Neil, President of Signia U.S. “Developing advanced hearing technology to best support hearing care professionals and their patients is at the core of Signia’s mission, and the Integrated Xperience platform does just that by pushing the boundaries of what hearing technology can do.”

As the world’s first hearing aid platform capable of pinpointing multiple conversation partners in real-time, Signia’s Integrated Xperience leverages insights into the changing positions of speakers to ensure uninterrupted engagement in even the most noisy, immersive environments.

Signia’s RealTime Conversation Enhancement

Integrated Xperience features Signia’s RealTime Conversation Enhancement solution that analyzes, augments, and adapts to the dynamic flow of multi-party conversation environments. The technology works in three stages, allowing wearers to engage, interact, and participate in noisy group conversations regardless of location, movement, and noise level.

The Integrated Xperience platform is currently available in Signia’s Pure Charge&Go IX and Silk Charge&Go IX hearing aid models, offering a substantial improvement in conversational ability for patients.

“The hearing aids built on Signia’s Integrated Xperience platform ultimately allow wearers to enjoy more meaningful lives with richer conversations,” said Nicholas Hort, Vice President of Marketing for Signia U.S. “With Integrated Xperience, we’ve set a new industry standard for hearing aid technology, prioritizing socialization, engagement, and a level of hearing ability that was previously unattainable in noisy, busy scenarios.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”